A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The primary purpose of this open-label phase 3 study is to evaluate the safety of HS-10380 on the incidence, severity, relationship to investigational product of adverse events (AE), serious adverse events (SAE), and adverse events leading to study drug discontinuationin Chinese adult participants with schizophrenia.
Epistemonikos ID: 4c2e018a10d36140cffad76e2070f43498c28b5f
First added on: Aug 12, 2026